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SUMMARY

Promoting brown adipose tissue (BAT) development
is an attractive strategy for the treatment of obesity,
as activated BAT dissipates energy through thermogenesis; however, the mechanisms controlling BAT
formation are not fully understood. We hypothesized
that as a master regulator of energy metabolism,
AMP-activated protein kinase (AMPK) may play a
direct role in the process and found that AMPKa1
(PRKAA1) ablation reduced Prdm16 expression and
impaired BAT development. During early brown adipogenesis, the cellular levels of a-ketoglutarate
(aKG), a key metabolite required for TET-mediated
DNA demethylation, were profoundly increased and
required for active DNA demethylation of the
Prdm16 promoter. AMPKa1 ablation reduced isocitrate dehydrogenase 2 activity and cellular aKG
levels. Remarkably, postnatal AMPK activation with
AICAR or metformin rescued obesity-induced suppression of brown adipogenesis and thermogenesis.
In summary, AMPK is essential for the epigenetic
control of BAT development through aKG, thus linking a metabolite to progenitor cell differentiation and
thermogenesis.

INTRODUCTION
Brown adipose tissue (BAT) burns fatty acids and glucose to
generate heat (Virtanen et al., 2009), providing a promising
therapeutic target against obesity and type 2 diabetes (T2D).

During brown adipogenesis, PR Domain Containing 16 protein
(PRDM16) not only commits progenitors to the brown adipogenic lineage but is also required for maintaining brown adipocyte identity (Seale et al., 2008). However, the regulation of
Prdm16 at the transcriptional level remains largely unexplored.
Prdm16 is enriched with CpG sites surrounding its transcription
start site (TSS), a characteristic of ‘‘key developmental genes’’
(Meissner et al., 2008). Promoters of key developmental genes
are enriched with both H3K4me3 and H3K27me3, forming a
‘‘bivalent state’’ (Mikkelsen et al., 2007). During early differentiation, non-induced bivalent genes in progenitors preserve repressive H3K27me3 mark (Schuettengruber and Cavalli, 2009), converting to relatively stable inhibition by inducing DNA methylation
(Mohn et al., 2008). Thus, active DNA demethylation is likely
needed for activating their expression during subsequent differentiation. Active DNA demethylation is mediated by the teneleven translocation hydroxylases (TETs), including TET1, 2,
and 3 (Ficz et al., 2011; Ito et al., 2010). Importantly, TET catalytic
reaction requires a-ketoglutarate (aKG), a key metabolite of the
Krebs cycle, linking metabolism to epigenetic modifications
(Wu and Zhang, 2014) and stem cell differentiation (Wu et al.,
2011b).
As a master regulator of cell metabolism, AMP-activated protein kinase (AMPK) positions as a key mediator of cell differentiation (Hardie, 2011). Recently, AMPK was proposed to regulate
brown fat (BAT) thermogenic function indirectly via altering
hypothalamus and adrenergic nervous system in adults (Martı́nez de Morentin et al., 2014; Whittle et al., 2012). Here, we hypothesized that AMPK directly regulates brown adipogenesis
through elevating aKG production and DNA demethylation in
the Prdm16 promoter of progenitor cells and AMPK is required
for effective brown adipogenesis.
Obesity is an epidemic problem and well known to suppress
AMPK activity (Steinberg et al., 2006). We found that obesity

542 Cell Metabolism 24, 542–554, October 11, 2016 ª 2016 Elsevier Inc.

inhibits AMPK activity, which reduces aKG concentration and
impedes Prdm16 expression, resulting in impaired BAT development and thermogenic function. Moreover, AMPK activation in
obese mice, using the common anti-diabetic drug metformin,
rescued BAT development and its thermogenic capacity. These
studies link AMPK and BAT development to aKG and to the
subsequent TET-mediated DNA demethylation of the Prdm16
promoter. Furthermore, they suggest that AMPK may be an
excellent drug target for promoting BAT development and for
treating obesity.
RESULTS
Brown Adipogenesis Is Impeded Due to Prkaa1 Ablation
The catalytic unit of AMPK has two isoforms, a1 (PRKAA1) and
a2. We found that Prkaa1 is prominently expressed in brown
progenitor cells (Figures S1A and S1B) in a manner resembling
its expression pattern during white adipogenesis (Daval et al.,
2005). In Prkaa1 / mice, the BAT mass was smaller than in
wild-type (WT) mice (Figures S1D and S1E), which was associated with a lower density of Lin /CD45 /Sca-1+ progenitor cells
and reduced Ki67+ cells (Figures S1F–S1I). The dorsal interscapular temperature (DIT) of Prkaa1 / mice was convincingly
lower than that of neonatal WT mice (Figure 1A), concomitant
with reduced UCP1 content (Figure 1B). Consistently, the
Prdm16 expression was attenuated in Prkaa1 / E15.5 BAT
(Figures S1K and S1L), a critical stage for early brown adipocyte commitment (Schulz et al., 2013). We then examined
BAT cellular structure using electron microscopy and determined that although the number of intracellular lipid droplets
was lower in Prkaa1 / mice, cell size was larger and lipid droplets were less uniformly distributed compared to those in
Prkaa1+/+ cells (Figures 1C and S1M). Mitochondrial density
was also lower in Prkaa1 / mice, and there was evidence of
poorly organized cristae (Figures 1D and S1J). Furthermore,
the mRNA expression of markers for brown adipogenesis was
reduced (Figure 1E). When subjected to the cold environment
for short durations, the body temperature of Prkaa1 / adult
mice was notably lower than that of WT mice that were similarly
exposed (Figure S2A). The long-term cold stimulus (11 days),
however, did not change body temperature, consistent with a
previous report (Bauwens et al., 2011). Long-term cold exposure induces a compensatory thermal adaptation that might
mask the effect of BAT deficiency on thermostasis (Schulz
et al., 2013). Stimulating cells in vitro with the b-adrenergic
agonist isoproterenol upregulate Ucp1 expression in both
WT and Prkaa1 / BAT, with responsiveness to be much
weaker in the latter (Figure S2B). Cold challenge substantially
reduced lipid droplet size in BAT of WT mice, but not in
Prkaa1 / BAT (Figure S2C). Consistently, in vivo, the Prkaa1deleted BAT was less responsive to the challenge of high-fat
diet (HFD) or cold stimulus (6 hr at 5 C) (Figure S2D). Together,
lipid utilization and thermogenesis in BAT of Prkaa1 / mice
was impaired. We therefore analyzed the AMP and ATP contents in both progenitor cells and BAT. In progenitor cells, acute
Prkaa1 knockout (KO) increased the AMP/ATP ratio, indicative
of impaired energy status. Surprisingly, the AMP level was
very high in BAT of young mice, which was likely due to highly
active uncoupling, which is consistent with previous reports

(Drahota et al., 1970; Pedersen and Grav, 1972). The AMP/
ATP ratio was also lower in Prkaa1 / BAT, showing attenuated
uncoupling and BAT function (Figures S2E and S2F). These
data clearly demonstrate the impairment of BAT function in
the absence of Prkaa1.
Because AMPK is capable of regulating BAT function indirectly through the sympathetic nervous system (Martı́nez de
Morentin et al., 2014; Whittle et al., 2012), we performed BAT
transplantation and acute deletion of Prkaa1 in progenitor cells
to demonstrate that endogenous PRKAA1 is critically required
for brown adipogenesis independent of sympathetic control.
First, we demonstrated that Cre recombinase expression
or 4-hydroxytamoxifen (0.25 mM) treatment did not affect
brown adipogenesis (Figure S1C), as previously reported (Cohen
et al., 2014). Then, BAT was isolated from neonatal Prkaa1flox/flox/
ER-Cre / and Prkaa1flox/flox/ER-Cre+/ mice of the same litter
and transplanted into WT recipient mice; after 21 days, the transplanted BAT grew and integrated into the BAT niche (Figures
S3A–S3C). Compared to WT BAT, the development of transplanted Prkaa1 / BAT and its thermogenic capacity were
severely hampered (Figures 1F, S3D, and S3E); as a negative
control, transplanted visceral fat did not generate heat (Figure S3F). Histologically, Prkaa1 KO rendered transplanted BAT
structurally similar to that of white adipose tissue (WAT) (Figure 1G) with reduced expression of brown adipocyte markers
(Figure 1H), underscoring the importance of Prkaa1 in brown
adipogenesis, which is independent of other physiological
influences.
During early development, brown adipocytes are originated
from progenitor cells of several different cell lineages (Peirce
et al., 2014; Tran et al., 2012) in addition to the well-known
Myf5+ lineage (Seale et al., 2008). We therefore used mouse
embryonic fibroblasts (MEFs) and brown stromal vascular cells
(BSVs) so that likely sources of progenitors were included. We
isolated BSVs from neonatal Prkaa1flox/flox/ER-Cre+/ mice,
treated with and without 4-hydroxytamoxifen, and induced
brown adipogenesis. Prkaa1 KO profoundly reduced the formation of brown adipocytes and mitochondrial abundance (Figures 2A–2D) as well as oxygen consumption and expression
of brown adipogenic markers (Figures 2E and 2F). We further
prepared E13.5 MEFs. In inducible Prkaa1 KO MEFs, fewer
brown adipocytes were detected by oil red O and UCP1 staining while glucose uptake was compromised (Figures S4A–
S4D). Transfecting C3H10T1/2 cells with Prkaa1/Cas9 plasmid
prevented differentiation into brown adipocytes as cells with
green fluorescence (Prkaa1 KO) remained spindle shaped,
while control cells (Scrambled/Cas9) became round shaped,
indicative of brown adipogenesis (Figure 2G). These results
unambiguously demonstrate the necessity of PRKAA1 in
brown adipogenesis. The differential brown adipogenesis was
further confirmed by oil red O staining and attenuated
PRDM16 and UCP1 expression (Figures 2H and 2I). However,
Prkaa1 KO after the commitment stage had no effect on the
number of brown adipocytes but changed the morphology of
mature adipocytes (Figures S4E–S4G).
Because a portion of brown progenitor cells is myogenic
(Seale et al., 2008), we induced myogenesis of BSVs isolated
from E18.5 fetuses, when BAT is actively developing. Myogenin,
a marker of myogenic differentiation, was much more abundant
Cell Metabolism 24, 542–554, October 11, 2016 543

Figure 1. Interscapular BAT Development Is Severely Impaired Due to Prkaa1 Ablation
(A) Body temperature of WT, heterozygous, and Prkaa1 KO mice at P1.
(B) Ucp1 expression at P1 (n = 4).
(C) Scanning electron microscopic images of BAT at P21 (scale bar, 50 mm).
(D) Transmission electron microscopic images of BAT from P21 mice (scale bars, 5 mm and 500 nm).
(E) Expression of BAT markers and selected markers of BAT separated from WT and Prkaa1 KO mice at P1 (n = 5).
(F–H) Neonatal BAT was isolated from Prkaa1 floxed mice with and without Cre and transplanted into a recipient mouse, and Prkaa1 KO was induced by tamoxifen
injection (see Figure S3A for the detailed protocol). At 21 days after transplantation, the thermogenesis of transplanted BAT from neonatal Prkaa1 KO mice (right)
was severely impaired compared to WT BAT (left) (F). The difference in the structure of transplanted BAT is shown (G; scale bar, 100 mm). mRNA expression of
brown adipocyte markers was profoundly reduced in transplanted BAT due to Prkaa1 deficiency (H; n = 3).
Gene mRNA expression was normalization to the 18S rRNA. *p < 0.05; **p < 0.01; ***p < 0.001; mean ± SEM; Student’s t test with a two-tailed distribution was
used; one-way ANOVA with Tukey’s post hoc test was used in (B).

in Prkaa1 / cells (Figure S4H). The shape of cells was primarily
round in WT cells, while Prkaa1 / cells formed long tubes (Figure S4I) and stained positive for myosin heavy chain (MHC) (Figure S4J). Consistently, MHC content was higher in the BAT of
Prkaa1 / E18.5 fetuses (Figure S4K). We also analyzed the
expression of white adipogenic markers during early brown adipogenesis, which was not affected by Prkaa1 loss (Figures S4L
and S4M). Thus, BSVs from Prkaa1 / mice possess a higher
capacity to undergo myogenesis.
544 Cell Metabolism 24, 542–554, October 11, 2016

DNA Demethylation in the Prdm16 Promoter Is Impaired
Due to Prkaa1 Ablation
Based on recent chromatin immunoprecipitation (ChIP)-sequencing data (Mikkelsen et al., 2007), the region surrounding
Prdm16 promoter has a great abundance of H3K27me3 and
H3K4me3, which colocalize with the CpG island, eliciting the
bivalent status of Prdm16 promoter (Ku et al., 2008). Moreover,
the core subunits of PRC2, EZH2 and SUZ12, colocalize with
TET1 in the CpG island (Xu et al., 2011b) (Figure S5A). During

Figure 2. Acute Prkaa1 Knockout Suppresses Brown Adipogenesis
(A–F) Brown stromal vascular cells (BSVs) were prepared from the brown adipose tissue of Prkaa1flox/flox/ER-Cre neonatal mice, and Prkaa1 KO was induced by
4-hydroxytamoxifen (4-HTO) after reaching confluence.
(A) Oil red O staining of BSVs at 7 days after inducing brown adipogenesis (scale bar, 400 mm).
(B) Immunoblotting of markers of BAT and mitochondria.
(C) Immunofluorescence staining of UCP1 after inducing brown adipogenesis (scale bar, 400 mm).
(D) Mitochondrial tracker (scale bar, 200 mm).
(E) Oxygen consumption of differentiated brown adipocytes from WT and KO BSVs.
(F) mRNA expression of related markers of brown adipocytes.
(G–I) Deleting Prkaa1 by CRISPR/Cas9 genome editing blocked brown adipogenesis. C3H10T1/2 cells were transfected with scrambled (Scr/Cas9) and Prkaa1
CRISPR/Cas9 plasmids, respectively, and then induced brown adipogenesis.
(G) Transfected cells (green fluorescence) with Prkaa1 ablation could not convert to brown adipocytes (remained spindle shape), while control cells (Scrambled/
Cas9) became brown adipocytes (round shape) (scale bar, 100 mm).
(H) Less brown adipocytes were detected by oil red O staining at day 7 (scale bar, 200 mm).
(I) Prkaa1 ablation reduced PRDM16 and UCP1 protein contents.
Gene mRNA expression was normalization to the 18S rRNA. **p < 0.01; ***p < 0.001; mean ± SEM; n = 3; Student’s t test with a two-tailed distribution.

brown adipogenic differentiation of BSVs, Prdm16 expression
peaked at day 3 (Figure 3A), which was blunted due to Prkaa1
KO (Figures 3A and 3B). Moreover, Prdm16 overexpression in
Prkaa1 KO cells restored brown adipogenesis (Figures 3C and
3D), showing the mediatory role of PRDM16.
To explore responsible epigenetic changes reducing Prdm16
expression, we focused on three specific regions in the
Prdm16 promoter, including tissue-specific DNA methylation
region (T-DMR) (Kron et al., 2013; Tan et al., 2014), the TSS,
which is located in the nucleosome-depleted region (NDR)
(Jones, 2012), and a GC-rich area in the gene body covered
by rich epigenetic modifications (Figure 3E). Consistent with
increased Prdm16 expression, the DNA methylation in these
three regions was reduced during differentiation (Figure 3F),
showing the occurrence of DNA demethylation. A recent global
genomic mapping study found that key developmental genes

are regularly enriched with 5hmC during differentiation (Pastor
et al., 2011; Wu et al., 2011a), and 5hmC presence repels
PRC2 binding (Wu et al., 2011b). Aligned with lower Prdm16
expression in Prkaa1 / cells, the PRC2-mediated inhibitory
histone modification, H2K27me3, was higher in the Prdm16
promoter (Figure S5B), and was accompanied by higher
5mC and lower 5hmC concentrations due to Prkaa1 KO (Figures 3G, 3H, and 3J). Meanwhile, 5hmC enrichment was
not detected in the Pparg2 promoter (Figure S5D), demonstrating that demethylation was locus specific. The expression of all Tets, which catalyze 5hmC formation, was
pronouncedly enhanced during brown adipogenic differentiation (Figure 3I), suggesting the importance of DNA demethylation during brown adipogenesis. On the other hand, the
expression of DNA methyltransferases (DNMTs) was unaltered
(Figure S5C).
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Figure 3. DNA Demethylation in the Prdm16 Promoter Is Impaired Due to Prkaa1 Ablation
(A and B) The mRNA expression (A) and protein content (Day 3) (B) of Prdm16 in WT and Prkaa1 KO cells during brown adipogenic differentiation of brown stromal
vascular cells (BSVs) (n = 3).
(C and D) Prdm16 ectopic expression rescues brown adipogenesis impaired due to Prkaa1 ablation. BSVs were separated from Prkaa1 floxed mice (n = 4). Then,
WT cells were transfected with eGFP plasmid, and Prkaa1 KO cells were transfected with either eGFP or Prdm16 overexpressing plasmid.
(C) Prdm16 overexpression increased PRDM16 content at day 3 of differentiation and brown adipogenesis stained by oil red O at day 7 (scale bar, 200 mm).
(D) Rescued expression of brown adipocyte markers in cells with PRKAA1 deficiency.
(E) Diagram showing three amplicon regions in the Prdm16 gene, including proximal tissue specific-DNA methylation (T-DMR, A), a nucleosome-depleted region
(NDR, B) and a GC island covered by rich epigenetic modifications (intergenic regulated region, C).
(F) Reduction of DNA methylation in Prdm16 promoter of BSVs before and 3 days of differentiation (n = 5 for 0 d, n = 4 for 3 d).
(G and H) Prkaa1 KO led to an increase of 5mC (G) and a reduction of 5hmC (H) in the Prdm16 promoter at day 3.
(I) Tet1, 2, and 3 expression before and 3 days after brown adipogenic differentiation (n = 3).
(J) Immunohistochemical staining of 5hmC at day 3 of differentiation (scale bar, 200 mm).
Gene mRNA expression was normalization to the 18S rRNA; immunoprecipitated target sequences were analyzed by qPCR and normalized to inputs. *p < 0.05;
**p < 0.01; ***p < 0.001; mean ± SEM; n = 5 unless otherwise indicated; Student’s t test with a two-tailed distribution.

Prkaa1 Ablation Impairs DNA Demethylation in the
Prdm16 Promoter via an aKG-Dependent Mechanism
We hypothesized that the availability of substrate, aKG, has a critical role in mediating DNA demethylation of the Prdm16 promoter.
We employed metabolomic analyses to identify metabolites in WT
and Prkaa1 / BSVs. Surprisingly, the concentration of aKG was
extremely low in both WT BSVs and E13.5 MEFs (Figures 4A and
4B). Compared to progenitors, aKG concentration was vastly
higher in BAT or differentiated brown adipocytes at day 3, while
citrate content only slightly differed between progenitor cells
and BAT (Figures 4A and 4B). Thus, aKG, due to its very low concentration (WT: 14.15 ± 2.2 mM at day 0; 33.49 ± 6.1 mM at day 3),
likely is the rate-limiting factor hindering TET-mediated DNA de546 Cell Metabolism 24, 542–554, October 11, 2016

methylation in progenitor cells considering aKG Km for TETs is
around 50–60 mM (Laukka et al., 2016) (Figure 4A). We further
compared metabolite contents between WT and Prkaa1 / cells
and found that aKG was reduced due to Prkaa1 KO (Figure 4C),
which was confirmed by chemical analysis (Figure 4D). We then
analyzed the expression of rate-limiting enzymes catalyzing
aKG generation. During differentiation, the expression of isocitrate dehydrogenases (IDH) were dramatically increased, which
might provide an explanation for the low aKG content in progenitor cells (Figure 4E). Furthermore, the expression of IDH2 was
suppressed due to the absence of Prkaa1 (Figures 4E and 4F).
We then analyzed the IDH2 acetylation that is known to reduce
its activity (Lombard et al., 2007; Someya et al., 2010; Yu et al.,

Figure 4. a-Ketoglutarate Concentration Is Reduced in Neonatal Brown Stromal Vascular Cells Due to Prkaa1 Ablation
(A and B) Metabolomic analyses of metabolites in E13.5 mouse embryonic fibroblasts (MEF), brown stromal vascular cells (BSV), and neonatal brown adipose
tissue (n = 6). Mass spectrum of a-ketoglutarate (A) and quantification of a-ketoglutarate content (B).
(C) Concentration of key metabolites of the TCA cycle of WT and Prkaa1 ablated cells (n = 6).
(D) Higher a-ketoglutarate concentration in WT compared to Prkaa1 ablated BSVs (n = 5).
(E) Isocitrate dehydrogenases (IDH) 1, 2, and 3 expression before and 3 days after brown adipogenic differentiation (n = 3).
(F) BSVs were separated from brown fat of WT and Prkaa1 conditional KO mice (AMPKa1 KO was induced by tamoxifen) and then induced brown adipogenesis
for 3 days. The IDH2 content was lower in Prkaa1 ablated cells, while IDH2 acetylation analyzed by immunoprecipitation was higher.
(G–I) a-Ketoglutarate supplementation rescues brown adipogenesis in Prkaa1 ablated cells (n = 3). a-Ketoglutarate (4 mM) was added during the commitment
stage (initial 3 days of brown adipogenic differentiation).
(G) Oil red O staining of BSVs at day 7 after inducing brown adipogenesis (scale bars, 400 mm and 200 mm).
(H) The mRNA expression of brown adipocyte markers at day 7 post-differentiation.
(I) 5hmC enrichment in the Prdm16 promoter at day 3 of differentiation.
Gene mRNA expression was normalization to the 18S rRNA; immunoprecipitated target sequences were analyzed by qPCR and normalized to inputs. *p < 0.05;
**p < 0.01; ***p < 0.001; mean ± SEM; n = 5 unless otherwise indicated; Student’s t test with a two-tailed distribution.

2012) and discovered that it was indeed increased with Prkaa1
KO (Figure 4F; Figure S6A). Thus, Prkaa1 deficiency inhibits
IDH2 activity. We then deleted Idh2 gene in C3H10T1/2 cells,

induced brown adipogenesis, and discovered that Idh2 KO
decreased aKG level (Figures S6B and S6C) and suppressed
PRDM16 content (Figure S6D), which was accompanied by
Cell Metabolism 24, 542–554, October 11, 2016 547

Figure 5. Supplementation of aKG in the Commitment Stage Enhances TET Activity and Facilitates Brown Adipogenesis
(A–D) aKG was added during the initial 3 days of brown adipogenesis in C3H10T1/2 cells. PRDM16 (at day 3) and UCP1 (at day 7) contents were enhanced
due to aKG supplementation (A); oil red O staining of brown adipocytes (B; scale bar, 200 mm) and UCP-1 content (C; scale bar, 100 mm) after 7 days
of brown adipogenic differentiation. aKG dose dependently enhanced brown adipogenesis based on qualification of oil red O staining by light absorbance at
530 nm (D).
(E–I) At the same concentration (1 mM), aKG enhanced while 2-hydroxyglutarate inhibited TET activity. Diethyl-a-ketoglutarate, diethyl-2-hydroxyglutarate, and
vehicle only were separately added to C3H10T1/2 cells during the initial 3 days of brown adipogenesis. aKG and 2-hydroxyglutarate did not affect Tet1, 2, and 3
expression (E); nuclear fraction was isolated at day 3 of differentiation, and extracts were used for analyzing TET activity (F); mRNA expression of brown adipocyte
markers at day 7 of differentiation (G); qualification of oil red O staining by light absorbance at 530 nm (H); images of oil red O staining of brown adipocytes at day 7
of differentiation (I; scale bar, 200 mm).
Gene mRNA expression was normalization to the 18S rRNA. Student’s t test with a two-tailed distribution. *p < 0.05; ***p < 0.001; ****p < 0.0001; n = 3; means ±
SEM; one-way ANOVA with Tukey’s post hoc test was used in (D), (F), and (H).

impaired brown adipogenesis (Figure S6E). In short, Prkaa1 regulates cellular aKG level at least partially through altering IDH2
activity.
We then questioned whether aKG can recover brown adipogenesis. In fact, supplementing dimethyl-a-ketoglutarate, a
membrane permeable aKG, in BSVs and C3H10T1/2 cells
enhanced brown adipogenesis (Figures 4G, 4H, and 5A–5D),
which was correlated with enrichment of 5hmC in the Prdm16
promoter (Figure 4I), showing enhanced DNA demethylation.
We further found that, at the same concentration, aKG enhanced
TET activity in the nuclei, while 2-hydroxyglutarate, an aKG
competitive inhibitor (Xu et al., 2011a), blocked TET activity
without changing Tet expression, accompanied by altered
548 Cell Metabolism 24, 542–554, October 11, 2016

brown adipogenesis (Figures 5E–5I). However, during white adipogenesis, aKG had no effect (Figures S6F–S6H), showing that
aKG specifically promotes brown adipogenesis. Furthermore,
Prkaa1 loss during white adipogenesis in inguinal SVF had no effect on white adipocyte commitment but enhanced expression
of mature adipogenic markers (Figure S6I–S6K).
Absence of Prkaa1 Mimics the Impact of Obesity on BAT
Properties
We found that the body temperature of neonates from obese
mothers (OB) was much lower than that of non-obese controls
(Con) (Figure 6A). While there was no difference in the litter sizes,
the death rate of OB neonates was much higher than that of Con

Figure 6. Obesity Impairs Brown Adipose Tissue Development, Similar to Prkaa1 KO Mice
(A) Infrared (up) and photographic (down) images of newborn mice. Left: offspring of maternal control mice (Con). Right: offspring of maternal obese mice (OB) at
the same scale.
(B) Litter sizes of neonates of Con and OB mothers.
(C) Tracing death rates during 0–96 hr after birth.
(D and E) OB impaired the development of BAT in offspring. OB reduced absolute weight of BAT of offspring mice at P0 (D) and P21 (E) (n = 10).
(F) H&E staining of sections from the interscapular regions of neonatal Con and OB mice (scale bar, 200 mm).
(G) During the early fetal development, MO suppressed p-AMPK (T172) level at E15.5.
(H) MO reduced a-ketoglutarate content in E15.5 fetal tissue (n = 5).
(I) mRNA expression of Prdm16 (Con = 4, OB = 5) at P0.
(J and K) Brown adipogenesis was impaired at P0. UCP1 contents (n = 3) (J) and immunofluorescence staining of UCP1 at P0 (scale bar, 200 mm) (K).
(L–N) BAT functionality in offspring of obese mothers was compromised. MO impaired BAT thermogenesis of P21 mice under cold exposure (6 hr, 5 C). Rectal
temperature (L), Ucp1 expression (M), and H&E staining (N; scale bar, 200 mm) of sections from the BAT of 3-month-old offspring fed with HFD (n = 4).
Gene mRNA expression was normalization to the 18S rRNA. *p < 0.05; ***p < 0.001; means ± SEM; Student’s t test with a two-tailed distribution.

and correlated with the low body temperature (Figures 6B and
6C), suggesting hypothermia might be a key mechanism leading
to neonatal death. This observation is consistent with relatively
high death rates of neonates of obese women (Chen et al.,
2009; Hoppenbrouwers, 2015). Sudden infant death syndrome
(SIDS) is relatively common and devastating, with poorly defined
etiology (Kinney and Thach, 2009). It suggests that the impaired
BAT function may be one of the key etiological factors, consistent with earlier observation of BAT deficiency in SIDS infants
during autopsy (Vijgen and van Marken Lichtenbelt, 2013). In
agreement, offspring of obese mice had a deficient BAT similar
to Prkaa1 KO mice (Figures 6D–6F, 6H–6K, S7A, and S7B). Inter-

estingly, the AMPK phosphorylation that correlates with AMPK
activity was much lower in OB compared to Con BAT at E15.5,
a critical stage for brown adipogenesis (Figure 6G). Furthermore,
Prdm16 expression was diminished in the BAT of obese neonates and weaning mice (Figures 6I and 7F), which was correlated with lower aKG content (Figure 6H), reminiscent of what
observed in Prkaa1 / mice. These data are supported by a
recent clinical study showing that maternal obesity (MO)
increased DNA methylation in the Prdm16 promoter in placenta
at birth (Côté et al., 2013). Consistently, the UCP1 expression
was reduced in E18.5 fetus of obese mothers (Figures S7C
and S7D). Therefore, we also analyzed the impact of cold
Cell Metabolism 24, 542–554, October 11, 2016 549

Figure 7. AMPK Agonists Ameliorates Impaired BAT Development in the Offspring of Obese Mice
(A) Infrared (up) and photographic (down) images of OB offspring (10 days old) that had been administered with metformin, AICAR or vehicle daily withdrawn 24 hr
before measurement.
(B–G) AMPKa agonists partially recover BAT function in the offspring of obese mice (metformin, AICAR, and vehicle administration daily up to P15, and samples
were collected at P21). The BAT weight (B) (n = 10), density of progenitor cells (C and D), oxygen consumption of both coupled and uncoupled (E), Prdm16 mRNA
expression (F), and H&E staining of sections from the BAT (G; scale bar, 200 mm) are shown.
(H) Scanning electron microscopic images of BAT at OB and 3-month-old Con offspring (scale bars, 100 and 50 mm).
(I) BATs were separated from WT and AMPK floxed mice and then transplanted into the same recipient mice (3 days after transplantation, recipient mice were
injected with tamoxifen daily for 4 days to induce Prkaa1 KO in transplanted Prkaa1flox/flox/Cre+/ BAT; also see Figure S3 and Supplemental Experimental
Procedures for the detailed protocol).
Gene mRNA expression was normalization to the 18S rRNA. *p < 0.05; **p < 0.01; ***p < 0.001; mean ± SEM; n = 4 unless otherwise indicated; one-way ANOVA
with Tukey’s post hoc test was used in (B), (C), and (E).

stimulus on the body temperature of weaning mice, and OB
offspring demonstrated impaired ability to maintain body temperature in a cold environment (Figure 6L), consistent with lower
Ucp1 expression (Figure 6M). Up to 3 months of HFD exposure,
the BAT of OB mice demonstrated a phenotype that resembled
white fat (Figure 6N). We demonstrated that under HFD exposure, the BAT identity of AMPK KO and OB mice was weakened,
with impaired ability of thermogenesis. These data clearly show
the impairment of BAT function in both Prkaa1 / mice and OB
offspring.
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AMPK Agonists Administrated during the Early Stage
Ameliorate Impaired BAT Development in Weaning
Obese Mice
The similarity of BAT phenotype between Prkaa1 / and obese
neonates suggested that suppression of Prkaa1 activity might
be a key mechanism impairing BAT development. Thus, activating AMPK in OB offspring should recover BAT development.
Indeed, the neonatal temperature was reduced due to MO and
largely recovered through the administration of both metformin
and AICAR, two activators of AMPK, after birth (Figure 7A). At

weaning (P21), BAT weights were partially recovered due to
AMPK activation (Figure 7B), which was associated with
increased density of Lin /CD45 /Sca-1+ progenitor cells (Figures 7C and 7D). Such recovery is striking considering that the
drug administration was initiated after birth and could only influence postnatal BAT development. In agreement, the oxygen
consumption of isolated BAT and browning identity marker
Prdm16 were increased due to metformin and AICAR treatments
(Figures 7E and 7F; Figures S7E and S7F). Consequently,
visceral fat weight was reduced in treated mice (Figure S7G),
consistent with a recent clinical report showing that BAT development and visceral fat accumulation are mutually antagonistic
(Wang et al., 2015). In addition, MO impaired glucose tolerance
of offspring (Figures S7H and S7I) at weaning, which was ameliorated by metformin. Histologically, BAT of OB mice developed
into WAT-like adipocytes compared to those of Con mice and
OB with AMPK agonists (Figures 7G and 7H). Because metformin affects whole body metabolism in addition to BAT, we
conducted a transplantation study. BATs were separated
from AMPK floxed mice with and without Cre and then transplanted into the same recipient mice (Figure S3). After inducing
Prkaa1 KO and treating with metformin, Prdm16 expression
was elevated only in WT transplanted BAT, not in Prkaa1 /
BAT, showing that metformin promoted brown adipogenesis
through AMPKa1 in vivo, independent of other physiological
changes (Figure 7I). Overall, these results show that drugs activating AMPK rescued BAT development and its functionality in
obese mice.
DISCUSSION
Our data delineate a key mechanism linking AMPK and BAT
development via changing an important metabolite, aKG, and
subsequent TET-mediated DNA demethylation in the Prdm16
promoter. AMPK is an excellent drug target to promote BAT
development under obese condition where AMPK activity is inhibited (Steinberg et al., 2006). The importance of this mechanism is further highlighted by the extremely low concentrations
of aKG and low Tet expression in progenitor cells and their surge
during early brown adipogenesis, suggesting the central role of
DNA demethylation in initiating brown adipocyte differentiation.
Our findings further reveal an intrinsic link between metabolism
and brown adipogenesis that is mediated by AMPK. Because
drugs activating AMPK are commonly used, such as metformin,
this mechanism provides a promising therapeutic strategy to
promote BAT development and reduce metabolic diseases.
Strikingly, we observed that there is a profound increase in
aKG concentration during the brown adipogenesis of progenitor
cells, which suggests a possible generic mechanism regulating
stem cell and progenitor differentiation, via vast upregulation of
IDH expression and aKG concentration, serving to facilitate
DNA demethylation of key developmental genes. This notion is
supported by the inhibitory roles of aKG and IDH in carcinogenesis (Possemato et al., 2011; Prensner and Chinnaiyan, 2011),
where cancer stem cells fail to undergo differentiation; on the
other hand, antagonization of aKG by its reduced form, an
oncometabolite 2-hydroxylglutarate, promotes oncogenesis
(Ye et al., 2012). Moreover, aKG extends lifespan in C. elegans
(Chin et al., 2014). Intriguingly, AMPK activation also inhibits tu-

mor growth (Faubert et al., 2013; Shackelford and Shaw, 2009)
and extends lifespan in C. elegans (Shackelford and Shaw,
2009). These data hint a fascinating possibility of priming the
expression of lineage specific genes via boosting AMPK/aKG
axis in order to treat cancers and other conditions.
Similar to the obesity epidemic in general population, more
than 30% of pregnant women are obese and another one-third
overweight in the United States (Flegal et al., 2012), which predisposes children to obesity and metabolic diseases (Lawlor
et al., 2012). Our discovery of impairment in BAT development
via the AMPK/aKG pathway due to obesity provides a drug
target for clinical interventions of obese pregnant women and
their children, thus curbing the physiological vicious cycle between MO and the obesity and T2D in children (Rando and Simmons, 2015). In fact, two multi-centric trials using metformin on
obese pregnant women and their children are ongoing (MOP:
NCT01273584 and EMPOWaR: ISRCTN51279843); it will be of
great interest to see whether BAT development is improved
with metformin treatment in these children. In addition, our
finding has a potential clinical link to SIDS, a devastating disease
(Kinney and Thach, 2009), on the basis of recent observation and
the death rates of neonates higher in obese women (Chen et al.,
2009; Leddy et al., 2008). Similarly, our discovery provides a potential drug target to enhance BAT thermogenic function and
thus curbs obesity in general population.
The clinical application of our discovery is further heightened
by those available dietary aKG supplements, such as ornithine
aKG, which are known for their anabolic effect (Donati et al.,
1999) and for potentially preventing sarcopenia (Walrand,
2010) and improving wound healing in burn patients (Donati
et al., 1999). Clinically, aKG administration in vivo protects
from ischemia-reperfusion injury (Olenchock et al., 2016).
Despite unestablished mechanisms for the anabolic effects of
aKG, these studies suggest the likely wide existence of AMPK/
aKG-mediated DNA demethylation in the processes of tissue
development and regeneration that are only limited to BAT.
EXPERIMENTAL PROCEDURES
Animals
Animal studies were conducted according to the protocol approved by the
Institute of Animal Use and Care Committees (IAUCC) at Washington State
University. Additional information about the animal studies is described in
the Supplemental Experimental Procedures.
Brown Fat Transplantation
Brown fat transplantation was conducted as previously described, with slight
modifications (Stanford et al., 2013). Experimental procedures are provided in
the Supplemental Experimental Procedures.
Cell Line, Plasmid Transfection, and Assays
The C3H10T1/2 cell line was purchased from ATCC and cultured in DMEM
containing 15% fetal bovine serum (FBS) at 37 C with 5% CO2. All details of
cell operations were described in the Supplemental Experimental Procedures.
2-Deoxy-D-Glucose Uptake Assay
Glucose uptake by differentiated brown adipocytes was analyzed using a
2-Deoxy-D-Glucose Uptake Kit (Cayman Chemical).
Oil Red O Staining of Lipid Droplets in Adipocytes
Oil red O staining was performed as previously described (Jimenez et al.,
2007).
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Oxygen Consumption Assays
Isolated BAT was weighed, and 20 mg of tissue slice was placed in a respiration buffer (2% BSA, 1.1 mM sodium pyruvate, and 25 mM glucose in PBS).
Similarly, cultured cells were replaced with the respiration buffer. Oxygen consumption was measured using an Orion Dissolved Oxygen platform (Thermo
Scientific) for approximately 25 min. Each sample was measured in triplicate
(Harms et al., 2014b).
aKG Assay
The aKG contents in BAT and differentiated brown adipocytes were analyzed
using an a-Ketoglutarate Assay Kit (Sigma).
Thermal Imagining
Thermo-images were taken using an E6 Thermal Imaging Infrared Camera
(FLIR Systems).
Metabolomic Analyses of BAT and BAT-Derived Stem Cells
Detailed protocols and analysis of data are described in the Supplemental
Experimental Procedures.
IDH2 Acetylation Assay
Cell lysates were centrifuged at 13,000 3 g for 10 min at 4 C, and the supernatant was pre-cleared with protein A/G magnetic beads (Thermo Fisher
Scientific). Subsequently, the lysates were incubated overnight at 4 C with
anti-IDH2 antibody (12652, Cell Signaling Technology) and then incubated
with protein A/G magnetic beads. Equivalent amounts of protein were
analyzed for each sample. The normal rabbit IgG (2729, Cell Signaling Technology) was used as the negative control. The beads-protein complexes
were boiled in SDS sample buffer and subjected to western blotting.
H&E Staining and Immunofluorescence Staining
Adipose tissues were fixed in 4% paraformaldehyde (PFA) for 24 hr at 4 C. After
dehydration, the tissues were embedded into paraffin and cut into 5-mm thick slices, deparaffinized, and rehydrated using standard methods. Sections were
stained with H&E. For immunohistochemical staining, antigen retrieval was performed by submerging in 0.01 M sodium citrate (pH 6.0) and heated to boil for
20 min in a microwave oven. BAT was subjected to immunofluorescence staining; antibodies against UCP1 were purchased from Santa Cruz Biotechnology
(sc-28766), and Ki67 (12202) was purchased from Cell Signaling Technology.
Mitochondrial Measurement
A Mitochondria Tracker Kit purchased was used to visualize mitochondria (Cell
Signaling Technology).
Transmission Electron Microscope and Scanned Electron
Microscope
The protocols were based on previous reports (Bartelt et al., 2011; Harms
et al., 2014a).
Glucose Tolerance Test
The assay was conducted as previously described (Stanford et al., 2013).
Statistical Analyses
Previous experiments done were used to determine sample size with adequate
statistical power. Results were analyzed using Student’s t test or one-way
ANOVA (for multiple comparison) where appropriate, using GraphPad Prism
software. All analyses were conducted with Student’s t test with a two-tailed
distribution, except recovery experiments (Figures 4H, 4I, and 7) where a
one-tailed distribution was used. All data were found to be normally distributed. Significance was accepted at p < 0.05. The researchers involved in experiments were not completely blinded during sample obtainment or data
analysis. All data are reported as mean ± SEM.
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